These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding. Kitchen D; Smith D Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022 [TBL] [Abstract][Full Text] [Related]
27. Recovery of phenytoin from an enteral nutrient formula. Hooks MA; Longe RL; Taylor AT; Francisco GE Am J Hosp Pharm; 1986 Mar; 43(3):685-8. PubMed ID: 3085485 [TBL] [Abstract][Full Text] [Related]
28. Causes of non-medication-induced nasogastric tube occlusion. Hofstetter J; Allen LV Am J Hosp Pharm; 1992 Mar; 49(3):603-7. PubMed ID: 1598935 [TBL] [Abstract][Full Text] [Related]
29. How to minimize interaction between phenytoin and enteral feedings: two approaches. Gilbert S; Hatton J; Magnuson B Nutr Clin Pract; 1996 Feb; 11(1):28-31. PubMed ID: 8700059 [No Abstract] [Full Text] [Related]
30. Drug-nutrient interactions in enteral feeding: a primary care focus. Varella L; Jones E; Meguid MM Nurse Pract; 1997 Jun; 22(6):98-104. PubMed ID: 9211455 [TBL] [Abstract][Full Text] [Related]
31. Is the phenytoin-enteral feeding formula interaction a myth? Bertino JS Nutr Clin Pract; 1996 Aug; 11(4):175-6. PubMed ID: 9070019 [No Abstract] [Full Text] [Related]
32. Effect of enteral tube feeding on serum phenytoin levels. Ozuna J; Friel P J Neurosurg Nurs; 1984 Dec; 16(6):289-91. PubMed ID: 6438282 [TBL] [Abstract][Full Text] [Related]
33. Comment: phenytoin and enteral feedings. Fitzsimmons WE; Garnett WR; Krueger KA Drug Intell Clin Pharm; 1988 Nov; 22(11):920. PubMed ID: 3148456 [No Abstract] [Full Text] [Related]
34. Nasogastric and nasoenteric feeding tubes. Levy H Gastrointest Endosc Clin N Am; 1998 Jul; 8(3):529-49. PubMed ID: 9654567 [TBL] [Abstract][Full Text] [Related]
35. [Interaction of Phenytoin with Enteral Formulas, Proteins, and Dietary Fiber in Vitro and in Vivo]. Kuwabara N; Ohta-Shimizu M; Fuwa F; Tsugita M; Sato N; Sato S; Nakagawa S Yakugaku Zasshi; 2023; 143(1):85-94. PubMed ID: 36596543 [TBL] [Abstract][Full Text] [Related]
36. Loss of carbamazepine suspension through nasogastric feeding tubes. Clark-Schmidt AL; Garnett WR; Lowe DR; Karnes HT Am J Hosp Pharm; 1990 Sep; 47(9):2034-7. PubMed ID: 2121028 [TBL] [Abstract][Full Text] [Related]
37. Minimizing respiratory complications of nasoenteric tube feedings: state of the science. Metheny N Heart Lung; 1993; 22(3):213-23. PubMed ID: 8491657 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic locking of enteral feeding tubes with pancreatic enzymes. Sriram K; Jayanthi V; Lakshmi RG; George VS JPEN J Parenter Enteral Nutr; 1997; 21(6):353-6. PubMed ID: 9406135 [TBL] [Abstract][Full Text] [Related]
39. Considerations of drug therapy in patients receiving enteral nutrition. Gora ML; Tschampel MM; Visconti JA Nutr Clin Pract; 1989 Jun; 4(3):105-10. PubMed ID: 2499752 [TBL] [Abstract][Full Text] [Related]